LW
WST icon

Linscomb Wealth’s West Pharmaceutical WST Stock Holding History

Linscomb Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,834
Closed -$888K – 385
2020
Q1 		$888K Sell
5,834
-1,115
-16% -$172K 0.08% 149
2019
Q4 		$1.04M Buy
+6,949
New +$1.01M 0.07% 208

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Linscomb Wealth's WST Position: Q2 2020 in Review

Linscomb Wealth sold out of West Pharmaceutical (WST) in Q2 2020, closing a stake of 5,834 shares — an estimated $888K sold.

Linscomb Wealth first reported a position in WST in Q4 2019 and held it in 2 quarters. The position peaked at $1.04M in Q4 2019. 524 funds tracked by Wall St. Rank hold WST as of Q2 2020.

  • Linscomb Wealth reported no remaining West Pharmaceutical position as of Q2 2020 after selling out during the quarter.
  • Linscomb Wealth sold 5,834 West Pharmaceutical shares in Q2 2020, an estimated $888K.
  • Linscomb Wealth first reported a position in West Pharmaceutical in Q4 2019 and held it in 2 quarters.
  • Linscomb Wealth's West Pharmaceutical position peaked at $1.04M in Q4 2019.
  • 524 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2020.

Based on Linscomb Wealth's 13F filing for Q2 2020, filed 11 Aug 2020.